Francesco Zaccardi Selected Research

Sitagliptin Phosphate (Januvia)

12/2020	Comparative effectiveness of gliclazide modified release versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes.
1/2020	Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials.
1/2020	A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
2/2011	Severe leucopenia associated with Sitagliptin use.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Zaccardi Research Topics

Disease

43	Type 2 Diabetes Mellitus (MODY) 04/2024 - 03/2009
17	COVID-19 01/2023 - 01/2021
9	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 12/2010
8	Stroke (Strokes) 01/2023 - 01/2018
7	Myocardial Infarction 02/2024 - 06/2017
7	Infections 01/2023 - 01/2021
7	Body Weight (Weight, Body) 03/2022 - 06/2015
6	Heart Failure 01/2023 - 02/2016
6	Obesity 01/2021 - 01/2019
5	Neoplasms (Cancer) 11/2023 - 04/2019
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 02/2015
5	Insulin Resistance 02/2016 - 01/2013
4	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 11/2011
4	Cardiac Arrhythmias (Arrythmia) 01/2022 - 08/2015
4	Inflammation (Inflammations) 01/2021 - 12/2010
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016 - 06/2006
3	Overweight 01/2021 - 01/2020
3	Venous Thromboembolism 01/2021 - 01/2018
3	Chronic Disease (Chronic Diseases) 01/2021 - 12/2019
3	Diabetes Mellitus 12/2019 - 01/2013
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2017 - 04/2015
3	Coronary Disease (Coronary Heart Disease) 06/2017 - 02/2015
2	Peripheral Arterial Disease 04/2024 - 10/2020
2	Hypertension (High Blood Pressure) 07/2023 - 11/2017
2	Human Influenza (Influenza) 01/2023 - 01/2011
2	Post-Acute COVID-19 Syndrome 09/2022 - 01/2022
2	Hyperglycemia 01/2022 - 05/2008
2	Myocarditis (Carditis) 01/2022 - 01/2022
2	Thromboembolism 01/2021 - 10/2019
2	Atrial Fibrillation 10/2020 - 08/2016
2	Glucose Intolerance 01/2020 - 05/2015
2	Heart Diseases (Heart Disease) 01/2019 - 08/2015
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2017 - 09/2009
2	Nausea 01/2017 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 05/2015
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Death (Near-Death Experience) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Bone Fractures (Bone Fracture) 01/2023
1	Dementia (Dementias) 01/2023
1	Herpes Zoster 01/2023
1	Thyrotoxicosis 11/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Ischemia 01/2022
1	Pain (Aches) 01/2022
1	Pericarditis 01/2022
1	Hemorrhagic Stroke 12/2021
1	Guillain-Barre Syndrome 12/2021

Drug/Important Bio-Agent (IBA)

29	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2009
10	Insulin (Novolin)FDA Link 10/2023 - 01/2013
10	VaccinesIBA 01/2023 - 01/2011
8	SodiumIBA 04/2024 - 01/2018
8	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 01/2016
8	COVID-19 VaccinesIBA 01/2023 - 01/2021
6	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2018
6	C-Reactive ProteinIBA 06/2017 - 01/2011
4	mRNA VaccinesIBA 01/2023 - 01/2021
4	BNT162 VaccineIBA 01/2022 - 01/2021
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
4	Sitagliptin Phosphate (Januvia)FDA Link 12/2020 - 02/2011
4	CholesterolIBA 10/2020 - 12/2009
4	HDL CholesterolIBA 06/2017 - 12/2009
4	Triglycerides (Triacylglycerol)IBA 01/2016 - 12/2009
3	LipidsIBA 07/2023 - 01/2019
3	Antidepressive Agents (Antidepressants)IBA 01/2023 - 01/2020
3	empagliflozinIBA 01/2023 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2018
3	ThromboxanesIBA 01/2020 - 04/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 03/2019
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2016
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2016
2	2019-nCoV Vaccine mRNA-1273IBA 01/2022 - 01/2022
2	Liraglutide FDA Link 01/2020 - 01/2020
2	CreatinineIBA 11/2017 - 08/2016
2	oxidized low density lipoproteinIBA 06/2017 - 08/2015
2	Exenatide (Byetta)FDA Link 01/2017 - 01/2016
2	rGLP-1 proteinIBA 01/2017 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 01/2011
2	Pioglitazone (Actos)FDA Link 12/2010 - 03/2009
2	Uric Acid (Urate)IBA 12/2009 - 05/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2009 - 05/2008
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Herpes Zoster VaccineIBA 01/2023
1	Antithyroid Agents (Antithyroid Drugs)IBA 11/2022
1	Pain-FreeIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	SolutionsIBA 01/2022

Therapy/Procedure

12	Therapeutics 02/2024 - 12/2010
4	Steam Bath (Sauna) 11/2018 - 04/2015
3	Surgical Amputation (Amputations) 04/2024 - 01/2020
3	Walkers 11/2023 - 12/2019
3	Glycemic Control 01/2023 - 11/2011
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2021
2	Bariatric Surgery 04/2019 - 11/2012
1	Deprescriptions 01/2023
1	Secondary Prevention 07/2022